1. Catalog
  2. NCKSAP: Cardiac Amyloidosis, 1st Edition (Reissue)
NCKSAP: Cardiac Amyloidosis, 1st Edition (Reissue)
Availability
On-Demand
Release on Mar 01, 2026 12:00 AM Central Standard Time
Access expires on Feb 28, 2027
Cost
Full Domestic Member: $169.00
Early-Career: $49.00
Emeritus: $49.00
Industry: $169.00
International Emerging Markets: $49.00
Full International Member: $129.00
Trainee: $49.00
Non-Physician (Member): $49.00
Physician (Non-Member): $299.00
Non-Physician (Non-Member): $299.00
Credit Offered
10 CME Credits
10 MOC Points
10 COP Credits
This is a self-assessment CME activity in online format consisting of 30 multiple-choice questions. Each question includes an answer rationale and references for further studying. This module will be updated every 3 years. It is designed for practitioners who are performing nuclear imaging studies and want to increase their competence for certification, recertification or general practice improvement.
This activity is designed for nuclear cardiology physicians.
Upon completion of this module, the learner will be able to:
  • Describe cardiac amyloidosis subtypes and identify symptoms, associated clinical conditions, and typical non-nuclear imaging features.
  • Identify appropriate clinical scenarios for the use of Tc99m-PYP/DPD/HMDP imaging in cardiac amyloidosis.
  • Apply appropriate Tc99m-PYP/DPD/HMDP, I123-MIBG, and SPECT/PET amyloid binding tracer standardized imaging techniques to optimize assessment of cardiac amyloidosis.
  • Interpret and communicate diagnostic and prognostic findings on Tc99m-PYP/DPD/HMDP, I123-MIBG, and SPECT/PET amyloid binding tracers in the assessment of cardiac amyloidosis.
The overall goal of this activity is to provide a comprehensive review of nuclear cardiology imaging procedures and best practices and increase physicians’ competence and performance in their ability to improve cardiovascular disease outcomes.
Release Date: March 1, 2026
Expiration Date: February 28, 2027
Powered By